The £500k GBP investment came from private UK business angels and the Wider Oxford Technology Angel Network (WOTAN) The funding will be used to support commercialization of the company’s innovative cryopreserved cell technology, scale up production of its assay-ready cells and expand its reach in the UK and Europe. CryoLogyx’s range of frozen, ready-to-use adherent cell lines offers scientists an efficient, reliable and cost-effective solution with enhanced reproducibility.